Within the tumor immune microenvironment, the quantity of CD4+T and CD8+T cells gradually diminishes as the tumor progresses, resulting in an imbalance in immune function and eventual evasion of immune surveillance (31). The gene discussed is CD8A; the disease is neoplasm.